Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra Indust | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 13.33B | 22.3x | 1.04 | SAR 166.40 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.1% Upside | Upgrade to Pro+ | |
Jamjoom Pharmaceuticals Factory | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 10.92B | 31.4x | 1.42 | SAR 157.20 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.4% Upside | Upgrade to Pro+ | |
Saudi chemical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 6.76B | 20.6x | 0.12 | SAR 7.98 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SPIMACO | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 3.35B | 98.8x | 1.09 | SAR 28 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
Middle East Pharmaceutical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 2.62B | 33.3x | 0.35 | SAR 131.60 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.9% Downside | Upgrade to Pro+ | |
Qomel | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 406M | 15.7x | 0.17 | SAR 117.40 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almujtama Alraida Medical Co SJSC | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 277.40M | 26.2x | SAR 29.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |